Anavar vs Winstrol: Cutting Goals, Doses and Trade-offs
Anavar vs Winstrol, at a glance
Both attract lifters trying to keep strength and look more defined during a cut. Anavar is often discussed for strength and fullness; Winstrol for a harder-looking finish. Some people report uncomfortable joints with either.
Anavar's “mild” reputation does not remove cholesterol or liver concerns. Winstrol's “dry” reputation does not prove better fat loss. There is no reliable head-to-head winner for either results or safety.
Anavar
Oxandrolone
Strength & fullnessPeople often focus on training performance and keeping a fuller look while dieting.
The “milder” reputationWinstrol
Stanozolol
A harder-looking finishPeople often focus on definition. Some also report uncomfortable joints.
The “dry” reputationThese are reported goals and reputations, not a head-to-head result or safety ranking.
Reported oral doses and duration
These are reported daily totals in an online-use compilation, not dose equivalents, prescriptions or established safe ranges.
Reported oral use in Mullen's compilation
| Compare | Anavar | Oral Winstrol |
|---|---|---|
| Men: total per day | 50–80 mg | 25–50 mg |
| Women: separate reported column | 10–20 mg | 5–10 mg |
| Cycle length & daily split | Not specified | Not specified |
Mullen et al., Table 1 combined user reports and supplier information. It did not test these amounts. The women’s column does not establish a safe threshold: lasting masculinizing changes remain possible. See the separate Anavar and Winstrol guides for study-specific duration examples.
Which gives a drier look?
“Dry” usually means more visible definition or less of a soft, watery appearance. It is a description of a look, not a measure of how much fat was lost.
People report different experiences with both drugs. Starting body fat, diet, glycogen, fluid balance and other drugs can change the result. Pumps or fuller muscles can look good in the gym without establishing a bigger lasting muscle gain.
There is human oxandrolone research showing changes in body composition and strength, but it is not a head-to-head cutting trial against Winstrol. The study population and regimen matter; a bodybuilding before-and-after photo cannot fill that gap.
What about joint pain?
Some people report joint discomfort with Winstrol; some also report it with Anavar. Pain is not a test for which drug is in a product. It also does not prove that a joint has literally “dried out.”
Anavar should not be treated as joint protection, and a steroid switch is not an injury treatment. Pain that changes how you move or train deserves assessment.
Cholesterol and liver effects can be invisible
A good appearance or comfortable workout does not reveal these effects. Human studies found unfavorable cholesterol changes with each drug:
- Oral stanozolol: a six-week crossover study in 11 male weightlifters found lower HDL and higher LDL. It compared stanozolol with injected testosterone, not Anavar. Thompson et al., 1989
- Oxandrolone: a 12-week placebo-controlled study in 32 men aged 60–87 found lower HDL and higher LDL during treatment. That is a different population and regimen, so the two trials cannot rank the drugs. Schroeder et al., 2004
Oxandrolone’s historical label also warns about serious liver effects and lasting virilization in women. FDA withdrew Oxandrin’s US approval in 2023 and determined it had been withdrawn for safety or effectiveness reasons. An old label is not evidence of current approval. Historical label; FDA determination.
Oral versus injectable does not settle the question
Anavar usually refers to oral oxandrolone. Winstrol may refer to oral stanozolol or an injectable suspension. They require separate route and formulation context.
Injecting stanozolol does not turn it into a different active steroid or remove product-quality and injection concerns. Severe liver injury has also been reported after injected stanozolol; a case report cannot tell us how often that happens. Published case report
The oral human trial above cannot establish an injected-drug exposure curve. There is also no supported milligram-for-milligram benefit conversion between Anavar and Winstrol.
Read the Anavar compound guide, oral Winstrol or injectable Winstrol for the relevant formulation.
Product claims and useful records
A price, brand name, pump or side effect does not verify what’s in a nonmedical product. If discussing an existing exposure with a clinician, record the product, route, stated amount, dates, other drugs and symptoms. Blood pressure, cholesterol and liver tests answer different questions; one reassuring result does not clear the others.
Common questions
Which is better for cutting?
Their reputations emphasize different goals, but the checked research does not establish a head-to-head performance winner. “Dryer” appearance is not the same as more fat loss or better safety.
Does Anavar protect joints compared with Winstrol?
That has not been established by the evidence checked here. Reports of more comfortable training are not proof of joint or tendon protection.
Can a liver supplement cancel out the risks?
No supplement in the cited evidence is established to neutralize these risks. Suspected injury needs assessment of the actual exposure.
Does a shorter half-life mean a shorter detection window?
Not reliably. Urinary metabolites and the test method are separate from the concentration curve.
Sources and review notes
Checked October 11, 2026. Reported experiences shape the questions; official labels and human studies support health claims. There is no head-to-head Anavar/Winstrol trial in the evidence used here.
- Mullen et al., 2020: Table 1’s online reported oral amounts; no tested daily split or cycle length.
- Thompson et al., 1989: 6 mg/day oral stanozolol versus 200 mg/week injected testosterone enanthate, six weeks, 11 male weightlifters. The study amounts are research context, not a proposed cutting regimen.
- Schroeder et al., 2004: metabolism: oxandrolone 20 mg/day versus placebo, 12 weeks, 32 men aged 60–87; lipid findings.
- Schroeder et al., 2004: body composition: the older-men trial’s muscle, strength and body-composition findings and follow-up after stopping. Not evidence of superiority over Winstrol.
- Stanozolol liver-injury case: one reported injected exposure with severe cholestasis; not an incidence estimate.
- Historical oxandrolone label and FDA’s 2023 determination: warnings and US regulatory history.
Related compounds & model context
Article citations are linked in the text. Related catalog entries have separate model inputs and source notes, which may include unverified estimates. See our methodology for model assumptions and limitations.